zynquista
guidehouse germany gmbh - sotagliflozin - dijabetes tip 1 - lijekovi koji se koriste u dijabetesu - zynquista prikazan kao dodatak terapije inzulina s ciljem poboljšanja kontrole glukoze kod osoba s dijabetesom tipa 1 s indeksom tjelesne mase (bmi) ≥ 27 kg/m2, koji se nije mogao postići adekvatnu kontrolu glukoze, unatoč optimalnu terapiju inzulina.
rybelsus
novo nordisk a/s - semaglutide - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - rybelsus indiciran za liječenje odraslih osoba s dijabetesom nedovoljno kontrolirano tipa 2 za bolju kontrolu glukoze kao dodatak prehrani i exerciseas, kada монотерапия метформина se smatra da je neprimjereno zbog netolerancije ili contraindicationsin kombinaciji s drugim lijekovima za liječenje šećerne bolesti. prema rezultatima istraživanja u vezi kombinacije, utjecaj na glikemijski kontrolu i kardiovaskularnih događaja, a u ispitivanih skupina, vidi 4. 4, 4. 5 i 5.
byooviz
samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - ophthalmologicals - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologicals - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologicals - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
risedon 2 mg/1 tableta film tableta
bosnalijek d.d. - risperidonskoj - film tableta - 2 mg/1 tableta - 1 film tableta sadrži: 2 mg risperidona
coldrex combogrip 500 mg/200 mg/10 mg prašak za oralnu otopinu
adriatic bst d.o.o., verovškova ulica 55, ljubljana, slovenija - paracetamol gvaifenezin fenilefrinklorid - prašak za oralnu otopinu - 500 mg + 200 mg + 10 mg - urbroj: svaka vrećica sadrži 500 mg paracetamola, 200 mg gvaifenezina i 10 mg fenilefrinklorida
coldrex maxgrip limun prašak za oralnu otopinu
adriatic bst d.o.o., verovškova ulica 55, ljubljana, slovenija - paracetamol fenilefrinklorid askorbatna kiselina - prašak za oralnu otopinu - 1000 mg + 10 mg + 40 mg/vrećica - urbroj: jedna vrećica praška za oralnu otopinu sadrži 1000 mg paracetamola, 10 mg fenilefrinklorida i 40 mg askorbatne kiseline
coldrex tablete
adriatic bst d.o.o., verovškova ulica 55, ljubljana, slovenija - paracetamol kofein fenilefrinklorid terpin hidrat askorbatna kiselina - tableta - 500 mg + 25 mg + 5 mg + 20 mg + 30 mg - urbroj: jedna tableta sadrži 500 mg paracetamola, 25 mg kofeina, 5 mg fenilefrinklorida, 20 mg terpin hidrata i 30 mg askorbatne kiseline
coldrex vrući napitak s okusom limuna prašak za oralnu otopinu
adriatic bst d.o.o., verovškova ulica 55, ljubljana, slovenija - paracetamol fenilefrinklorid askorbatna kiselina - prašak za oralnu otopinu - 750 mg + 10 mg + 60 mg - urbroj: jedna vrećica s praškom za oralnu otopinu sadrži 750 mg paracetamola, 10 mg fenilefrinklorida i 60 mg askorbatne kiseline